Bio-Techne completed the acquisition of Namocell.

Synopsis

Bio-Techne, a developer, manufacturer and seller of life science reagents, completed the acquisition of Namocell, a cell sorting and dispensing platform. Financial terms were not disclosed.

Principals

target

NAMOCELL

bidder

Bio-techne Corp

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context